TW202513048A - 含有米羅巴林之醫藥組成物 - Google Patents

含有米羅巴林之醫藥組成物 Download PDF

Info

Publication number
TW202513048A
TW202513048A TW113119971A TW113119971A TW202513048A TW 202513048 A TW202513048 A TW 202513048A TW 113119971 A TW113119971 A TW 113119971A TW 113119971 A TW113119971 A TW 113119971A TW 202513048 A TW202513048 A TW 202513048A
Authority
TW
Taiwan
Prior art keywords
solid preparation
pharmaceutically acceptable
acceptable salt
reducing sugar
less
Prior art date
Application number
TW113119971A
Other languages
English (en)
Chinese (zh)
Inventor
宮野友紀
小林謙吾
Original Assignee
日商第一三共股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商第一三共股份有限公司 filed Critical 日商第一三共股份有限公司
Publication of TW202513048A publication Critical patent/TW202513048A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
TW113119971A 2023-06-02 2024-05-30 含有米羅巴林之醫藥組成物 TW202513048A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2023-091991 2023-06-02
JP2023091991 2023-06-02

Publications (1)

Publication Number Publication Date
TW202513048A true TW202513048A (zh) 2025-04-01

Family

ID=93658131

Family Applications (1)

Application Number Title Priority Date Filing Date
TW113119971A TW202513048A (zh) 2023-06-02 2024-05-30 含有米羅巴林之醫藥組成物

Country Status (5)

Country Link
JP (1) JPWO2024248079A1 (https=)
KR (1) KR20260018020A (https=)
CN (1) CN121218983A (https=)
TW (1) TW202513048A (https=)
WO (1) WO2024248079A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119732941B (zh) * 2024-12-30 2026-04-28 上海博悦生物科技有限公司 含有苯磺酸美洛加巴林的药物组合物及其制备方法
CN120531691B (zh) * 2025-06-20 2026-04-28 苏州美诺医药科技有限公司 一种苯磺酸美洛加巴林固体药物组合物、制剂及其制备方法
CN121221543A (zh) * 2025-11-26 2025-12-30 华润双鹤利民药业（济南）有限公司 一种苯磺酸美洛加巴林口崩片制剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2657219B1 (en) 2007-09-28 2014-12-10 Daiichi Sankyo Company, Limited Intermediate for producing bicyclic y-amino acid derivative
CN104334169B (zh) 2013-04-04 2016-11-02 第一三共株式会社 包含氨基羧酸盐的固体组合物
BR112017019918B1 (pt) 2015-03-19 2023-11-07 Daiichi Sankyo Company, Limited Preparação sólida farmacêutica, e, método para produzir uma preparação sólida farmacêutica para estabilizar uma preparação sólida farmacêutica
BR112017019920B1 (pt) 2015-03-19 2023-11-07 Daiichi Sankyo Company, Limited Preparação sólida farmacêutica, e, método para estabilização de uma preparação sólida farmacêutica
BR112021001008A2 (pt) 2018-07-30 2021-04-20 Daiichi Sankyo Company, Limited comprimido de fármaco
ES3025936T3 (en) * 2019-12-23 2025-06-10 Daiichi Sankyo Co Ltd Film-coated tablets having smooth surface
CN115803020A (zh) * 2020-07-27 2023-03-14 第一三共株式会社 含有苯磺酸米洛巴林的口腔崩解片剂

Also Published As

Publication number Publication date
WO2024248079A1 (ja) 2024-12-05
JPWO2024248079A1 (https=) 2024-12-05
KR20260018020A (ko) 2026-02-06
CN121218983A (zh) 2025-12-26

Similar Documents

Publication Publication Date Title
TW202513048A (zh) 含有米羅巴林之醫藥組成物
ES2354030T3 (es) Preparación farmacéutica sólida que comprende benzacepinas, y procedimiento de producción de la misma.
JP2010524991A (ja) プレガバリンを含有する安定化された医薬組成物
WO2006123678A1 (ja) ドロキシドパを含有する安定な錠剤
TWI808349B (zh) 含有芳基烷基胺化合物之醫藥組合物
US10583087B2 (en) Pharmaceutical composition for oral administration
JP4901966B2 (ja) 小型化塩酸サルポグレラート経口投与製剤
TW202011950A (zh) 含安定劑之醫藥品的固體製劑
AU2021410896A1 (en) Oral solid preparation
JP4567640B2 (ja) 小型化塩酸サルポグレラート経口投与製剤
JP2015182991A (ja) 口腔内崩壊錠
JP5823592B2 (ja) 安定性が改善された製剤
CN110494139B (zh) 含有纳呋拉啡的经片剂化的药物组合物
JP2021155359A (ja) レボカルニチンを有効成分とする錠剤
JP2024067030A (ja) ミラベグロン含有放出制御医薬組成物及びその製造方法
JP6918393B1 (ja) 漢方エキス又は植物性生薬エキスを含む固形製剤及びその製造方法、並びに固形製剤の崩壊性を向上させる方法
US9775832B2 (en) Pharmaceutical composition for oral administration
JP2000336032A (ja) ピペラジンアセトアミド誘導体を含有する徐放性経口医薬品組成物
CA3125814C (en) METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION COMPRISING NEFOPAM AND ACETAMINOPHEN, AND THE PHARMACEUTICAL COMPOSITION THUS OBTAINED
TW201808290A (zh) 經光穩定性提升之固體製劑
JPWO2011099573A1 (ja) 徐放性製剤
HK40129253A (zh) 含有米洛巴林的医药组合物
RU2799763C2 (ru) Способ производства фармацевтической композиции, содержащей нефопам и ацетаминофен, и полученная на их основе фармацевтическая композиция
WO2019221215A1 (ja) ルビプロストン含有粒子状医薬組成物
JP4393119B2 (ja) ヨウ化イソプロパミド含有製剤